Tag: CRC

Biomarker, Innovation

Mainz Biomed to assess mRNA biomarkers integration into cancer test

February 7, 2022


Mainz Biomed has initiated the ColoFuture clinical study to assess the integration of a new mRNA biomarkers portfolio into its ColoAlert test for colorectal cancer (CRC). ColoAlert is an easy-to-use, non-invasive test designed to detect tumour DNA and CRC cases […]